Cargando…
Development of a Compartmental Pharmacokinetic Model for Molecular Radiotherapy with (131)I-CLR1404
Pharmacokinetic modeling of the radiopharmaceuticals used in molecular radiotherapy is an important step towards accurate radiation dosimetry of such therapies. In this paper, we present a pharmacokinetic model for CLR1404, a phospholipid ether analog that, labeled with (124)I/(131)I, has emerged as...
Autores principales: | Neira, Sara, Gago-Arias, Araceli, Gónzalez-Crespo, Isabel, Guiu-Souto, Jacobo, Pardo-Montero, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465706/ https://www.ncbi.nlm.nih.gov/pubmed/34575575 http://dx.doi.org/10.3390/pharmaceutics13091497 |
Ejemplares similares
-
A Phase 1 Study of (131)I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety
por: Grudzinski, Joseph J., et al.
Publicado: (2014) -
Quantification of internal dosimetry in PET patients II: Individualized Monte Carlo‐based dosimetry for [18F]fluorocholine PET
por: Neira, Sara, et al.
Publicado: (2021) -
Quantification of internal dosimetry in PET patients: individualized Monte Carlo vs generic phantom‐based calculations
por: Neira, Sara, et al.
Publicado: (2020) -
EPCT-09. CLR 131 IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC MALIGNANCIES
por: Puccetti, Diane, et al.
Publicado: (2020) -
Radiobiological Meta-Analysis of the Response of Prostate Cancer to Different Fractionations: Evaluation of the Linear–Quadratic Response at Large Doses and the Effect of Risk and ADT
por: Pardo-Montero, Juan, et al.
Publicado: (2023)